Heldmann Marcus, Chatterjee Krishna, Moran Carla, Rogge Berenike, Steinhardt Julia, Wagner-Altendorf Tobias, Göttlich Martin, Schacht Hannes, Schramm Peter, Brabant Georg, Münte Thomas F, Cirkel Anna
Department of Neurology, University of Lübeck, Lübeck, Germany.
Department of Psychology II, University of Lübeck, Lübeck, Germany.
Endocr Connect. 2022 Jan 19;11(1):e210473. doi: 10.1530/EC-21-0473.
Thyroid hormone action is mediated by two forms of thyroid hormone receptors (α, β) with differential tissue distribution. Thyroid hormone receptor β (TRβ) mutations lead to resistance to thyroid hormone action in tissues predominantly expressing the β form of the receptor (pituitary, liver). This study seeks to identify the effects of mutant TRβ on pituitary size.
High-resolution 3D T1-weighted magnetic resonance images were acquired in 19 patients with RTHβ in comparison to 19 healthy matched controls. Volumetric measurements of the pituitary gland were performed independently and blinded by four different raters (two neuroradiologists, one neurologist, one neuroscientist).
Patients with mutant TRβ (resistance to thyroid hormone β, RTHβ) showed elevated free tri-iodothyronine/thyroxine levels with normal thyroid-stimulating hormone levels, whereas healthy controls showed normal thyroid hormone levels. Imaging revealed smaller pituitary size in RTHβ patients in comparison to healthy controls (F(1,35) = 7.05, P = 0.012, partial η2 = 0.17).
RTHβ subjects have impaired sensitivity to thyroid hormones, along with decreased size of the pituitary gland.
甲状腺激素的作用由两种甲状腺激素受体(α、β)介导,它们在组织中的分布存在差异。甲状腺激素受体β(TRβ)突变导致在主要表达该受体β形式的组织(垂体、肝脏)中对甲状腺激素作用产生抵抗。本研究旨在确定突变型TRβ对垂体大小的影响。
对19例RTHβ患者和19例健康匹配对照者进行高分辨率三维T1加权磁共振成像。垂体体积测量由四名不同的评估者(两名神经放射科医生、一名神经科医生、一名神经科学家)独立进行且在不知情的情况下完成。
突变型TRβ患者(甲状腺激素β抵抗,RTHβ)的游离三碘甲状腺原氨酸/甲状腺素水平升高,促甲状腺激素水平正常,而健康对照者甲状腺激素水平正常。影像学检查显示,与健康对照者相比,RTHβ患者的垂体较小(F(1,35) = 7.05,P = 0.012,偏η2 = 0.17)。
RTHβ患者对甲状腺激素的敏感性受损,同时垂体体积减小。